Combination therapy comprising an FGFR inhibitor and a KRAS inhibitor

The present disclosure relates to methods of treating cancer by administering a compound, which is a Fibroblast Growth Factor Receptor (FGFR) inhibitor, in combination with a Kirsten rat sarcoma (KRAS) inhibitor.

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	POLAM, PADMAJA, FAVATA, MARGARET, GAN, PEI, YE, QIN-DA, HE, CHUNHONG, WANG, HUI, MCCAMMANT, MATTHEW, YIN, HAO-LIN, SUSICK, ROBERT, RIOS-DORIA, JONATHAN, WEE, SUSAN, SOKOLSKY, ALEXANDER, SHVARTSBART, ARTEM, MIN, CHANG, LI, YONG, YAO, WENQING, LI, GENNG, CARLSEN, PETER, QI, CHAO, HU, BIN, WANG, XIAO-ZHAO, LAW, CHUNYIN MARSHALL, ZHU, WENYU, ARJONA, ALEJANDRO AMADOR, POLICARPO, ROCCO, ABDOLLAHI, ANGELA, ROACH, JEREMY, YANG, JEFFREY C, ZHAO, LE, HOANG, GIA, ZHANG, FENGLEI
Format:	Patent
Sprache:	chi ; eng
Schlagworte:	HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present disclosure relates to methods of treating cancer by administering a compound, which is a Fibroblast Growth Factor Receptor (FGFR) inhibitor, in combination with a Kirsten rat sarcoma (KRAS) inhibitor.